$0.7536
-0.0479-5.97%
Últ. Act.: Oct 23, 10:19 AM
Compass Therapeutics (CMPX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.11 | $-0.10 | $-0.09 | $-0.14 |
| Actual | $-0.13 | $-0.10 | $-0.09 | $-0.08 |
| Surprise | -18.2% | 0.00% | 0.00% | +42.9% |
| Revenue | ||||
| Estimate | $-514290 | $-642860 | — | — |
| Actual | $0 | $0 | — | — |
| Surprise | +100.0% | +100.0% | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.13 | $-0.13 | $-0.12 | $-0.13 |
| Revenue | ||||
| Consensus | $211620 | $-2.0M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.13 | $-0.11 | -18.2 % |
| Q1 | May 5, 2026 | $-0.10 | $-0.10 | 0.00 % |
| Q4 | Mar 5, 2026 | $-0.09 | $-0.09 | 0.00 % |
| Q3 | Nov 5, 2025 | $-0.08 | $-0.14 | 42.9 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $0 | $-514.29K | 100.0 % |
| Q1 | May 5, 2026 | $0 | $-642.86K | 100.0 % |